165 related articles for article (PubMed ID: 25471732)
1. Inhibition of S6K1 enhances dichloroacetate-induced cell death.
Hong SE; Shin KS; Lee YH; Seo SK; Yun SM; Choe TB; Kim HA; Kim EK; Noh WC; Kim JI; Hwang CS; Lee JK; Hwang SG; Jin HO; Park IC
J Cancer Res Clin Oncol; 2015 Jul; 141(7):1171-9. PubMed ID: 25471732
[TBL] [Abstract][Full Text] [Related]
2. S6K1 inhibition enhances tamoxifen-induced cell death in MCF-7 cells through translational inhibition of Mcl-1 and survivin.
Hong SE; Kim EK; Jin HO; Kim HA; Lee JK; Koh JS; Seol H; Kim JI; Park IC; Noh WC
Cell Biol Toxicol; 2013 Aug; 29(4):273-82. PubMed ID: 23942996
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of S6K1 enhances glucose deprivation-induced cell death via downregulation of anti-apoptotic proteins in MCF-7 breast cancer cells.
Choi HN; Jin HO; Kim JH; Hong SE; Kim HA; Kim EK; Lee JK; Park IC; Noh WC
Biochem Biophys Res Commun; 2013 Mar; 432(1):123-8. PubMed ID: 23376066
[TBL] [Abstract][Full Text] [Related]
4. Multi-modality imaging to assess metabolic response to dichloroacetate treatment in tumor models.
Neveu MA; De Preter G; Joudiou N; Bol A; Brender JR; Saito K; Kishimoto S; Grégoire V; Jordan BF; Krishna MC; Feron O; Gallez B
Oncotarget; 2016 Dec; 7(49):81741-81749. PubMed ID: 28082726
[TBL] [Abstract][Full Text] [Related]
5. Dichloroacetate enhances apoptotic cell death via oxidative damage and attenuates lactate production in metformin-treated breast cancer cells.
Haugrud AB; Zhuang Y; Coppock JD; Miskimins WK
Breast Cancer Res Treat; 2014 Oct; 147(3):539-50. PubMed ID: 25212175
[TBL] [Abstract][Full Text] [Related]
6. Dichloroacetate potentiates tamoxifen-induced cell death in breast cancer cells via downregulation of the epidermal growth factor receptor.
Woo SH; Seo SK; Park Y; Kim EK; Seong MK; Kim HA; Song JY; Hwang SG; Lee JK; Noh WC; Park IC
Oncotarget; 2016 Sep; 7(37):59809-59819. PubMed ID: 27494858
[TBL] [Abstract][Full Text] [Related]
7. Acidosis-induced metabolic reprogramming in tumor cells enhances the anti-proliferative activity of the PDK inhibitor dichloroacetate.
Schoonjans CA; Joudiou N; Brusa D; Corbet C; Feron O; Gallez B
Cancer Lett; 2020 Feb; 470():18-28. PubMed ID: 31812695
[TBL] [Abstract][Full Text] [Related]
8. Activation of mitochondrial oxidation by PDK2 inhibition reverses cisplatin resistance in head and neck cancer.
Roh JL; Park JY; Kim EH; Jang HJ; Kwon M
Cancer Lett; 2016 Feb; 371(1):20-9. PubMed ID: 26607904
[TBL] [Abstract][Full Text] [Related]
9. Sensitization of breast cancer cells to paclitaxel by dichloroacetate through inhibiting autophagy.
Wang M; Liao C; Hu Y; Qinwen Pan ; Jiang J
Biochem Biophys Res Commun; 2017 Jul; 489(2):103-108. PubMed ID: 28528979
[TBL] [Abstract][Full Text] [Related]
10. Sensitization of metformin-cytotoxicity by dichloroacetate via reprogramming glucose metabolism in cancer cells.
Choi YW; Lim IK
Cancer Lett; 2014 May; 346(2):300-8. PubMed ID: 24480191
[TBL] [Abstract][Full Text] [Related]
11. Superior anti-tumor efficacy of diisopropylamine dichloroacetate compared with dichloroacetate in a subcutaneous transplantation breast tumor model.
Su L; Zhang H; Yan C; Chen A; Meng G; Wei J; Yu D; Ding Y
Oncotarget; 2016 Oct; 7(40):65721-65731. PubMed ID: 27582548
[TBL] [Abstract][Full Text] [Related]
12. Dichloroacetate and PX-478 exhibit strong synergistic effects in a various number of cancer cell lines.
Parczyk J; Ruhnau J; Pelz C; Schilling M; Wu H; Piaskowski NN; Eickholt B; Kühn H; Danker K; Klein A
BMC Cancer; 2021 Apr; 21(1):481. PubMed ID: 33931028
[TBL] [Abstract][Full Text] [Related]
13. Dichloroacetate shifts the metabolism from glycolysis to glucose oxidation and exhibits synergistic growth inhibition with cisplatin in HeLa cells.
Xie J; Wang BS; Yu DH; Lu Q; Ma J; Qi H; Fang C; Chen HZ
Int J Oncol; 2011 Feb; 38(2):409-17. PubMed ID: 21132264
[TBL] [Abstract][Full Text] [Related]
14. ¹H NMR metabolomics analysis of the effect of dichloroacetate and allopurinol on breast cancers.
Lefort N; Brown A; Lloyd V; Ouellette R; Touaibia M; Culf AS; Cuperlovic-Culf M
J Pharm Biomed Anal; 2014 May; 93():77-85. PubMed ID: 24074721
[TBL] [Abstract][Full Text] [Related]
15. TRAIL restores DCA/metformin-mediated cell death in hypoxia.
Hong SE; Kim CS; An S; Kim HA; Hwang SG; Song JY; Lee JK; Hong J; Kim JI; Noh WC; Jin HO; Park IC
Biochem Biophys Res Commun; 2016 Sep; 478(3):1389-95. PubMed ID: 27569287
[TBL] [Abstract][Full Text] [Related]
16. Targeting of two aspects of metabolism in breast cancer treatment.
Gang BP; Dilda PJ; Hogg PJ; Blackburn AC
Cancer Biol Ther; 2014; 15(11):1533-41. PubMed ID: 25482950
[TBL] [Abstract][Full Text] [Related]
17. Targeting HIF-1α is a prerequisite for cell sensitivity to dichloroacetate (DCA) and metformin.
Hong SE; Jin HO; Kim HA; Seong MK; Kim EK; Ye SK; Choe TB; Lee JK; Kim JI; Park IC; Noh WC
Biochem Biophys Res Commun; 2016 Jan; 469(2):164-70. PubMed ID: 26616058
[TBL] [Abstract][Full Text] [Related]
18. Dichloroacetate induces regulatory T-cell differentiation and suppresses Th17-cell differentiation by pyruvate dehydrogenase kinase-independent mechanism.
Makita N; Ishiguro J; Suzuki K; Nara F
J Pharm Pharmacol; 2017 Jan; 69(1):43-51. PubMed ID: 27757958
[TBL] [Abstract][Full Text] [Related]
19. Hypoxia enhances antitumor activity of dichloroacetate.
Kolesnik DL; Pyaskovskaya ON; Boichuk IV; Solyanik GI
Exp Oncol; 2014 Dec; 36(4):231-5. PubMed ID: 25537215
[TBL] [Abstract][Full Text] [Related]
20. Combined use of arginase and dichloroacetate exhibits anti-proliferative effects in triple negative breast cancer cells.
Verma A; Lam YM; Leung YC; Hu X; Chen X; Cheung E; Tam KY
J Pharm Pharmacol; 2019 Mar; 71(3):306-315. PubMed ID: 30362115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]